Clinical Trial Update: Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)

View source ↗

Summary

This clinical trial update notes the completion of Avonex's pregnancy exposure registry (interferon beta-1a). It is used to monitor prenatal exposures and poten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Prenatal Exposure Delayed Effects, Multiple Sclerosis | Status: COMPLETED